Cited by 676Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsEndometriosis Research and Treatment

The DOI matches its Crossref record; 285 of the 288 references it cites were found in a registry or an index.

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

Open access

Conway, Gerard, Dewailly, Didier, Diamanti-Kandarakis, Evanthia, Escobar-Morreale, Héctor F, Franks, Stephen, Gambineri, Alessandra, Kelestimur, Fahrettin, Macut, Djuro, Micic, Dragan, Pasquali, Renato, Pfeifer, Marija, Pignatelli, Duarte, Pugeat, Michel, Yildiz, Bulent O·2014·European Journal of Endocrinology

DOI 10.1530/eje-14-0253

Open this paper in CoChat — free account

Abstract

Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with androgen excess in women, which justifies the growing interest of endocrinologists. Great efforts have been made in the last 2 decades to define the syndrome. The presence of three different definitions for the diagnosis of PCOS reflects the phenotypic heterogeneity of the syndrome. Major criteria are required for the diagnosis, which in turn identifies different phenotypes according to the combination of different criteria. In addition, the relevant impact of metabolic issues, specifically insulin resistance and obesity, on the pathogenesis of PCOS, and the susceptibility to develop earlier than expected glucose intolerance states, including type 2 diabetes, has supported the notion that these aspects should be considered when defining the PCOS phenotype and planning potential therapeutic strategies in an affected subject. This paper offers a critical endocrine and European perspective on the debate on the definition of PCOS and summarises all major aspects related to aetiological factors, including early life events, potentially involved in the development of the disorder. Diagnostic tools of PCOS are also discussed, with emphasis on the laboratory evaluation of androgens and other potential biomarkers of ovarian and metabolic dysfunctions. We have also paid specific attention to the role of obesity, sleep disorders and neuropsychological aspects of PCOS and on the relevant pathogenetic aspects of cardiovascular risk factors. In addition, we have discussed how to target treatment choices based according to the phenotype and individual patient's needs. Finally, we have suggested potential areas of translational and clinical research for the future with specific emphasis on hormonal and metabolic aspects of PCOS.

Integrity signals

Registry

Crossref · 10.1530/eje-14-0253

Cites

285 of 285 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
Retracted
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Untitled work
(1992) · PubMed · Cited by 33,716
Society and the Adolescent Self-Image
Rosenberg, M. (1965) · doi:10.1515/9781400876136 · Cited by 30,126
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238

Show all 288 references

Research works printed but not linked: 16

2013, Journal of endocrinological investigation, 36, 1004
Vermeulen, 1999, Journal of Clinical Endocrinology & Metabolism, 84, 3666, 10.1210/jc.84.10.3666 · DOI · Paper page
2004, Journal of Clinical Endocrinology & Metabolism, 83, 1273
2012, The Journal of pediatric endocrinology, 25, 983
2014, Journal of Clinical Endocrinology & Metabolism, 29, 135
Insenser, 2011, Journal of endocrinological investigation, 34, 869
2011, Molecular and cellular endocrinology, 15, 30
Fogel, 2001, Journal of Clinical Endocrinology & Metabolism, 86, 1175, 10.1210/jc.86.3.1175 · DOI · Paper page
Kelly, 2002, Journal of Clinical Endocrinology & Metabolism, 87, 742, 10.1210/jc.87.2.742 · DOI
2012, Clinical endocrinology, 78, 438
Solomon, 2002, Journal of Clinical Endocrinology & Metabolism, 87, 2013, 10.1210/jc.87.5.2013 · DOI · Paper page
2010, COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 20, 003053CD
2001, INTERNATIONAL JOURNAL OF OBESITY AND RELATED METABOLIC DISORDERS, 25, 781
2013, European Journal of Endocrinology, 170, R75
Moghetti, 2000, Journal of Clinical Endocrinology & Metabolism, 85, 89, 10.1210/jc.85.1.89 · DOI
White, 1996, Journal of Clinical Endocrinology & Metabolism, 81, 3821, 10.1210/jc.81.11.3821 · DOI

Sorted by citations

Items 201–300 of 672

The Application of Nanoparticle‐Based Imaging and Phototherapy for Female Reproductive Organs Diseases
Luo, L., Zhou, H., Wang, S., Mei, P., Zhang, J., Hu, Y., & You, J. (2023) · Small · doi:10.1002/smll.202207694 · Cited by 27
Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results
Yetim, A., Yetim, Ç., Baş, F., Erol, O. B., Çığ, G., Uçar, A., & Darendelıler, F. (2016) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.3253 · Cited by 27
Adrenal hyperandrogenism does not deteriorate insulin resistance and lipid profile in women with PCOS
Paschou, S. Α., Palioura, E., Ioannidis, D., Anagnostis, P. G., Panagiotakou, A., Loi, V., Karageorgos, G., Goulis, D. G., & Vryonidou, A. (2017) · Endocrine Connections · doi:10.1530/ec-17-0239 · Cited by 26
Metformin and health outcomes: An umbrella review of systematic reviews with meta‐analyses
Li, X., Celotto, S., Pizzol, D., Gašević, D., Ji, M., Barnini, T., Solmi, M., Stubbs, B., Smith, L., Sánchez, G. F. L., et al. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13536 · Cited by 27
Association of LH/FSH ratio with menstrual cycle regularity and clinical features of patients with polycystic ovary syndrome
Mitrašinović‐Brulić, M., Buljan, M., & Suljević, D. (2021) · Middle East Fertility Society Journal · doi:10.1186/s43043-021-00085-0 · Cited by 32
Free testosterone is related to aspects of cognitive function in women with and without polycystic ovary syndrome
Sukhapure, M., Eggleston, K., Douglas, K. M., Fenton, A. J., FRAMPTON, C. M. A., & Porter, R. (2021) · Archives of Women s Mental Health · doi:10.1007/s00737-021-01158-9 · Cited by 26
Medical comorbidity in polycystic ovary syndrome with special focus on cardiometabolic, autoimmune, hepatic and cancer diseases: an updated review
Glintborg, D., & Andersen, M. (2017) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000410 · Cited by 24
Serum visfatin levels in non-obese women with polycystic ovary syndrome and matched controls
Kim, J., Choi, Y. M., Hong, M. A., Kim, M.-J., Chae, S. J., Kim, S. M., Hwang, K. R., Yoon, S. H., Ku, S., Suh, C. S., et al. (2018) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2018.61.2.253 · Cited by 26
Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome
Lazúrová, I., Lazúrová, Z., Figurová, J., Ujhazi, S., Dravecká, I., Mašlanková, J., & Mareková, M. (2019) · Physiological Research · doi:10.33549/physiolres.934062 · Cited by 26
Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents
Calcaterra, V., Cena, H., Sottotetti, F., Hruby, C., Madini, N., Zelaschi, N., & Zuccotti, G. (2023) · Nutrients · doi:10.3390/nu15163582 · Cited by 27
“In the first phase, patients follow a VLCKD (around 600 and 800 kcal/day) or a LCKD (>800 kcal/day and <total energy expenditure) (50); the latter is preferred to meet needs and avoid deficiencies in adolescents with PCOS [56,59].”
Background
Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome
Papaetis, G. S., Filippou, P. K., Constantinidou, K. G., & Stylianou, C. S. (2020) · Clinical Drug Investigation · doi:10.1007/s40261-020-00942-2 · Cited by 25
The Effectiveness and Safety of Exenatide Versus Metformin in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials
Ye, Z.-R., Yan, C., Liao, N., & Wen, S.-H. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01222-y · Cited by 26
Ultrasound Evaluation in Female Infertility
Campbell, S. C. (2019) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2019.08.001 · Cited by 24
Polycystic ovary Syndrome in Adolescents: Pitfalls in Diagnosis and Management
Kostopoulou, E., Anagnostis, P. G., Bosdou, J. Κ., Spiliotis, B. E., & Goulis, D. G. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00388-9 · Cited by 24
Updates on Molecular Targets and Epigenetic-Based Therapies for PCOS
Смирнов, В. В., Beeraka, N. M., Butko, D. Y., Nikolenko, V. N., Bondarev, S., Achkasov, E. E., Sinelnikov, M. Y., & Vikram, P. R. H. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01013-x · Cited by 25
Liver X Receptors: A Possible Link between Lipid Disorders and Female Infertility
Dallel, S., Tauveron, I., Brugnon, F., Baron, S., Lobaccaro, J. A., & Maqdasy, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082177 · Cited by 28
Dietary intake, body composition and metabolic parameters in women with polycystic ovary syndrome
Cunha, N. B. D., Ribeiro, C. T., Silva, C. M., Rosa-e-Silva, A. C. J. D. S., & De-Souza, D. A. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.10.012 · Cited by 22
The Effect of Ageing on Clinical, Hormonal and Sonographic Features Associated with PCOS—A Long-Term Follow-Up Study
Jacewicz‐Święcka, M., Wołczyński, S., & Kowalska, I. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102101 · Cited by 23
Declining muscle NAD+ in a hyperandrogenism PCOS mouse model: Possible role in metabolic dysregulation
Aflatounian, A., Paris, V. R., Richani, D., Edwards, M. C., Cochran, B. J., Ledger, W. L., Gilchrist, R. B., Bertoldo, M. J., Wu, L. E., & Walters, K. A. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101583 · Cited by 23
Managing polycystic ovary syndrome in primary care
Lua, A., How, C. H., & King, T. (2018) · Singapore Medical Journal · doi:10.11622/smedj.2018135 · Cited by 23
Metformin Therapy for the Management of Infertility in Women with Polycystic Ovary Syndrome
(2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14764 · Cited by 24
Free Testosterone Reflects Metabolic as well as Ovarian Disturbances in Subfertile Oligomenorrheic Women
Antonio, L., Pauwels, S., Laurent, M. R., Vanschoubroeck, D., Jans, I., Billen, J., Claessens, F., Decallonne, B., De Neubourg, D., Vermeersch, P., et al. (2018) · International Journal of Endocrinology · doi:10.1155/2018/7956951 · Cited by 30
Contribution of high-fat diet-induced PCSK9 upregulation to a mouse model of PCOS is mediated partly by SREBP2
Guo, W., Wang, Y., Ma, Y.-D., Cui, Z., Zhang, L.-X., Nie, L., Zhang, X., Wang, M., Zhang, J., Yuan, D., et al. (2021) · Reproduction · doi:10.1530/rep-21-0164 · Cited by 22
Ovulation induction using sequential letrozole/gonadotrophin in infertile women with PCOS: a randomized controlled trial
Dai, X., Li, J., Fu, T., Long, X., Li, X., Weng, R., Liu, Y., & Zhang, L. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.08.002 · Cited by 22
Therapeutic Potential of Mesenchymal Stem Cells in PCOS
Nejabati, H. R., Nikzad, S., & Roshangar, L. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230517123256 · Cited by 22
Polycystic Ovary Syndrome in Adolescents: Which MR Imaging–based Diagnostic Criteria?
Fondin, M., Rachas, A., Huynh, V., Franchi‐Abella, S., Teglas, J. P., Duranteau, L., & Adamsbaum, C. (2017) · Radiology · doi:10.1148/radiol.2017161513 · Cited by 22
Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews
Tay, C. T., Joham, A. E., Hiam, D., Gadalla, M. A., Pundir, J., Thangaratinam, S., Teede, H. J., & Moran, L. (2018) · Clinical Endocrinology · doi:10.1111/cen.13753 · Cited by 23
RETRACTED ARTICLE: Long-term effects of combined simvastatin and metformin treatment on the clinical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome
Seyam, E., & Hefzy, E. M. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1490405 · Cited by 22
Retracted
Stanowisko Polskiego Towarzystwa Endokrynologicznego, Polskiego Towarzystwa Ginekologów i Położników oraz Polskiego Towarzystwa Endokrynologii Ginekologicznej w sprawie diagnostyki i leczenia zespołu policystycznych jajników
Milewicz, A., Kudla, M. J., Spaczyński, R., Dębski, R., Męczekalski, B., Wielgoś, M., Ruchała, M., Małecka‐Tendera, E., Kos‐Kudła, B., Jędrzejuk, D., et al. (2018) · Endokrynologia Polska · doi:10.5603/ep.2018.0046 · Cited by 22
Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome
Mehrabian, F., Tehrani, H. G., Mohamadkhani, M., Moinoddini, M., & Karimzadeh, P. (2016) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.177354 · Cited by 21
Maternal prolactin is associated with glucose status and PCOS in pregnancy: Odense Child Cohort
Overgaard, M., Glintborg, D., Christesen, H. T., Jensen, T. K., & Andersen, M. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0144 · Cited by 21
Anti-Müllerian hormone levels in the diagnosis of adolescent polycystic ovarian syndrome: a systematic review and meta-analysis
Tsukui, Y., Kitahara, Y., Hasegawa, Y., Kobayashi, M., Osuka, S., & Iwase, A. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0081 · Cited by 23
Developmental Programming: Gestational Exposure to Excess Testosterone Alters Expression of Ovarian Matrix Metalloproteases and Their Target Proteins
Puttabyatappa, M., Irwin, A. B., Martin, J. D., Mesquitta, M., Veiga‐Lopez, A., & Padmanabhan, V. (2017) · Reproductive Sciences · doi:10.1177/1933719117697127 · Cited by 21
Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
Τζιόμαλος, Κ., & Dinas, K. D. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00149 · Cited by 24
Estradiol/testosterone and estradiol/androstenedione indexes and nutritional status in PCOS women – A pilot study
Franik, G., Maksym, M., Owczarek, A. J., Chudek, J. T., Madej, P., & Olszanecka‐Glinianowicz, M. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2019.05.045 · Cited by 21
What does a diagnostic label of ‘polycystic ovary syndrome’ really mean in adolescence? a review of current practice recommendations
Morris, S., Grover, S. R., & Sabin, M. A. (2015) · Clinical Obesity · doi:10.1111/cob.12123 · Cited by 20
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome
Selen, D. J., & Powe, C. E. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000769 · Cited by 23
Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome
Livadas, S., Paparodis, R. D., Anagnostis, P. G., Gambineri, A., Μacut, D., Petrović, T., Yıldız, B. O., Micić, D., Mastorakos, G. P., & Μacut, D. (2023) · Diagnostics · doi:10.3390/diagnostics13122067 · Cited by 23
Self-citation
Diagnostic accuracy of oral glucose tolerance tests, fasting plasma glucose and haemoglobin A1c for type 2 diabetes in women with polycystic ovary syndrome: A systematic review and meta-analysis
Belsti, Y., Enticott, J., Azumah, R., Tay, C. T., Moran, L., Ronald, C. W., Joham, A. E., Laven, J. S. E., Teede, H. J., & Mousa, A. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.102970 · Cited by 27
Is cardiorespiratory fitness impaired in PCOS women? A review of the literature
Donà, S., Bacchi, E., & Moghetti, P. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0599-1 · Cited by 20
MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
PUGEAT, M. M., Plotton, I., de la Perrière, A. B., Raverot, G., Déchaud, H., & Raverot, V. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0776 · Cited by 20
Self-citation
Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone
Oriolo, C., Fanelli, F., Castelli, S., Mezzullo, M., Altieri, P., Corzani, F., Pelusi, C., Repaci, A., Dalmazi, G. D., Vicennati, V., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01235-3 · Cited by 20
Self-citation
Serum Anti-Müllerian hormone in polycystic ovary syndrome and its relationship with insulin resistance, lipid profile and adiponectin
Jelani, A. M., Jun, T., Omar, J., Rahim, R. A., & Yaacob, N. M. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_305_19 · Cited by 21
Effect of obstructive sleep apnea on in vitro fertilization outcomes in women with polycystic ovary syndrome
Zhang, Q., Wang, Z., Ding, J., Yan, S., Hao, Y., Chen, H., Yang, J., & Hu, K. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10780 · Cited by 19
How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology
Moghetti, P., Carmina, E., Leo, V. D., Lanzone, A., Orio, F., Pasquali, R., & Toscano, V. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0274-y · Cited by 19
Self-citation
Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
Quinn, M. M., Kao, C., Ahmad, A., Lenhart, N. J., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.06.026 · Cited by 20
Polycystic ovary syndrome in familial partial lipodystrophy type 2 [Fpld2]: Basic and clinical aspects
Gambineri, A., & Zanotti, L. (2018) · Nucleus · doi:10.1080/19491034.2018.1509659 · Cited by 19
Self-citation
Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes
Ortiz-Flores, A. E., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1528231 · Cited by 20
Self-citation
Metabolic Perspectives for Non-classical Congenital Adrenal Hyperplasia With Relation to the Classical Form of the Disease
Μacut, D., Zdravković, V., Bjekić-Macut, J., Mastorakos, G. P., & Pignatelli, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00681 · Cited by 20
Self-citation
Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome
Zheng, S., Tong, M., Dong, L., Du, C., Zheng, X. M., Wang, L., Huang, P., Liu, W., Lin, M., & Liu, C. (2020) · Endocrine Connections · doi:10.1530/ec-19-0559 · Cited by 19
Current treatment for polycystic ovary syndrome: focus on adolescence
Street, M. E., Cirillo, F., Catellani, C., Dauriz, M., Lazzeroni, P., Sartori, C., & Moghetti, P. (2020) · Minerva Pediatrics · doi:10.23736/s0026-4946.20.05861-2 · Cited by 19
The Relationship of Metabolic Syndrome and Body Composition in Children with Premature Adrenarche: Is It Age Related?
Williams, K. M., Oberfield, S. E., Zhang, C., McMahon, D. J., & Sopher, A. B. (2015) · Hormone Research in Paediatrics · doi:10.1159/000441498 · Cited by 19
Unfavorable Hormonal and Psychologic Profile in Adult Women with a History of Premature Adrenarche and Pubarche, Compared to Women with Polycystic Ovary Syndrome
Livadas, S., Bothou, C., Kanaka‐Gantenbein, C., Chiotis, D., Angelopoulos, N., Μacut, D., & Chrousos, G. P. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1109-2630 · Cited by 18
Prenatal Androgen Exposure and Traits of Autism Spectrum Disorder in the Offspring: Odense Child Cohort
Palm, C. V. B., Glintborg, D., Find, L. G., Larsen, P. V., Dalgaard, C. M., Boye, H., Jensen, T. K., Dreyer, A. F., Andersen, M., & Bilenberg, N. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05446-w · Cited by 19
Prospective Risk of Type 2 Diabetes in Normal Weight Women with Polycystic Ovary Syndrome
Glintborg, D., Kolster, N. D., Ravn, P., & Andersen, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061455 · Cited by 18
Changes in Mood, Anxiety, and Cognition with Polycystic Ovary Syndrome Treatment: A Longitudinal, Naturalistic Study
Sukhapure, M., Eggleston, K., Fenton, A. J., FRAMPTON, C. M. A., Porter, R., & Douglas, K. M. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s385014 · Cited by 18
Emotional and psychosexual well‐being is influenced by ethnicity and birthplace in women and individuals with polycystic ovary syndrome in the UK and India
Sheikh, J., Khalil, H., Shaikh, S., Hebbar, M., Zia, N., Wicks, S., Jayaprakash, S., Narendran, A., Subramanian, A., Malhotra, K., et al. (2023) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17428 · Cited by 18
Targets to treat androgen excess in polycystic ovary syndrome
Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1075511 · Cited by 18
Self-citation
High salivary testosterone‐to‐androstenedione ratio and adverse metabolic phenotypes in women with polycystic ovary syndrome
Münzker, J., Lindheim, L., Adaway, J., Trummer, C., Lerchbaum, E., Pieber, T. R., Keevil, B. G., & Obermayer-Pietsch, B. M. (2016) · Clinical Endocrinology · doi:10.1111/cen.13299 · Cited by 18
Postnatal depression in a community‐based study of women with polycystic ovary syndrome
March, W. A., Whitrow, M. J., Davies, M. J., Fernandez, R. C., & Moore, V. (2018) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13332 · Cited by 18
Polycystic Ovary Syndrome Signs and Metabolic Syndrome in Premenopausal Hispanic/Latina Women: the HCHS/SOL Study
Meyer, M. L., Sotres‐Alvarez, D., Steiner, A. Z., Cousins, L. M., Talavera, G. A., Cai, J., Daviglus, M. L., & Loehr, L. R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa012 · Cited by 19
Reproductive Endocrinology in Recurrent Pregnancy Loss
Krog, M. C., Nielsen, H. S., Christiansen, O. B., & Kolte, A. M. (2016) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000225 · Cited by 19
Comparison of exenatide alone or combined with metformin versus metformin in the treatment of polycystic ovaries: a systematic review and meta-analysis
Hu, Y. P., Song, X., Hamiti, S., Ma, Y., Yusufu, M., Wang, X., Zhang, K., & Guo, Y. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01497-x · Cited by 17
Development of a nutrition screening tool to identify need for dietetic intervention in female infertility
Kumar, K. D., Huntriss, R., Green, E., Bora, S., & Pettitt, C. (2022) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.13055 · Cited by 17
Metabolic Syndrome Rather Than Other Phenotypes in PCOS as a Predictive Indicator for Clinical Outcomes in IVF: Comprehensive Phenotypic Assessment across All PCOS Classifications
Si, M., Xu, W., Qi, X., Jiang, H., Zhao, Y., Li, R., Long, X., & Qiao, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12155073 · Cited by 16
Birth Weight and Polycystic Ovary Syndrome in Adult Life: Is There a Causal Link?
Paschou, S. Α., Ioannidis, D., Vassilatou, E., Mizamtsidi, M., Panagou, M., Lilis, D., Tzavara, I., & Vryonidou, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122050 · Cited by 17
Third trimester cortisol status is associated with offspring sex and polycystic ovary syndrome status: Odense Child Cohort
Andersen, M., Jensen, R. C., Schmedes, A., Brandslund, I., Kyhl, H. B., Jensen, T. K., & Glintborg, D. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.05.013 · Cited by 17
Integrated metabolomics and network pharmacology to reveal the therapeutic mechanism of Dingkun Pill on polycystic ovary syndrome
Cai, Y., Zhang, F., Dou, X., Zeng, H., Wu, G., Liang, Y., Xu, X., Zhao, J., Ye, J., & Zhang, W. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115442 · Cited by 17
Impact of Autoimmune Thyroiditis on Reproductive and Metabolic Parameters in Patients with Polycystic Ovary Syndrome
Ulrich, J., Goerges, J., Keck, C., Müller‐Wieland, D., Diederich, S., & Janssen, O. E. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-110480 · Cited by 18
Endocrine Disorders and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
Betlejewska, J., Hubska, J., Roszkowska, Z., Maciejczyk, A., Bachurska, D., Domański, J., Miarka, M., Raszeja‐Wyszomirska, J., Bobrowicz, M., & Ambroziak, U. (2025) · Biomedicines · doi:10.3390/biomedicines13102500 · Cited by 20
Probiotic Bifidobacterium lactis V9 regulates the intestinal microbiome in patients with polycystic ovary syndrome
Ma, C., Peng, Q., Jiang, S., Chen, K., Fang, Y., & Zhang, J. (2018) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972018-00587 · Cited by 16
Key signalling pathways underlying the aetiology of polycystic ovary syndrome
Walters, K. A., Moreno-Asso, A., Stepto, N. K., Pankhurst, M. W., Paris, V. R., & Rodgers, R. J. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0059 · Cited by 19
Adiponectin as a Serum Marker of Adipose Tissue Dysfunction in Women with Polycystic Ovary Syndrome: Correlation with Indicators of Metabolic Disturbances
Boshku, A. A. (2018) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2018.346 · Cited by 16
Glucocorticoid signaling and lipid metabolism disturbances in the liver of rats treated with 5α-dihydrotestosterone in an animal model of polycystic ovary syndrome
Milutinović, D. V., Teofilović, A., Veličković, N. A., Brkljačić, J. M., Jelača, S., Djordjevic, A. D., & Μacut, D. (2021) · Endocrine · doi:10.1007/s12020-020-02600-1 · Cited by 17
The PNA mouse may be the best animal model of polycystic ovary syndrome
Ren, J., Tan, G., Ren, X., Lu, W., Peng, Q., Tang, J. P., Wang, Y., Xie, B., & Wang, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.950105 · Cited by 16
Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
Diri, H., Karaburgu, S., Açmaz, B., Ünlühızarcı, K., Tanrıverdi, F., Karaca, Z., & Keleştimur, F. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1080679 · Cited by 16
A genetic risk score is associated with polycystic ovary syndrome-related traits
Lee, H., Oh, J. Y., Sung, Y., & Chung, H. W. (2015) · Human Reproduction · doi:10.1093/humrep/dev282 · Cited by 16
Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?
Walters, K. A., & Handelsman, D. J. (2015) · Asian Journal of Andrology · doi:10.4103/1008-682x.161600 · Cited by 16
Does asporin have a role in polycystic ovary syndrome? A pilot study
Özay, Y., Özay, A. C., Özay, Ö. E., & Edebal, O. H. (2022) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20220005 · Cited by 15
Clinical evaluation of patients living with obesity
Dobbie, L. J., Matta-Coelho, C., Crane, J. D., & McGowan, B. M. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03263-2 · Cited by 21
Diagnosis and management of infertility in patients with polycystic ovary syndrome (PCOS): guidelines from the Italian Society of Human Reproduction (SIRU) and the Italian Centers for the Study and Conservation of Eggs and Sperm (CECOS Italy)
Palomba, S., Seminara, G., Tomei, F., Marino, A. A., Morgante, G., Baldini, D., Papaleo, E., Ragusa, G., Aversa, A., Allegra, A., et al. (2025) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-025-01372-5 · Cited by 15
Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
Yang, Y.-M., & Choi, E. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s89737 · Cited by 18
Midlife women’s health consequences associated with polycystic ovary syndrome
Ali, A. T., & Guidozzi, F. (2019) · Climacteric · doi:10.1080/13697137.2019.1679111 · Cited by 16
A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
Pasquali, R., & Gambineri, A. (2015) · Women s Health · doi:10.2217/whe.15.13 · Cited by 15
Self-citation
Patterns of Bariatric Surgeries Among U.S. Women Diagnosed with Polycystic Ovarian Syndrome
Beydoun, H. A., Beydoun, M. A., Hossain, S. A., Stadtmauer, L., Eid, S. M., & Zonderman, A. B. (2020) · Journal of Women s Health · doi:10.1089/jwh.2019.7947 · Cited by 16
Timing of Maximal Weight Reduction Following Bariatric Surgery: A Study in Chinese Patients
Xu, T., Wang, C., Zhang, H., Han, X., Liu, W., Han, J., Yu, H., Chen, J., Zhang, P., & Di, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00615 · Cited by 13
Assessment of Optimism in Women with Polycystic Ovary Syndrome: A Case Control-Study
Morán‐Sánchez, I., Adoamnei, E., Sánchez-Ferrer, M. L., Prieto‐Sánchez, M. T., Árense-Gonzalo, J. J., Carmona‐Barnosi, A., Peñalver, A. I. H., Mendiola, J., & Torres-Cantero, A. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18052352 · Cited by 14
Hyperandrogen-induced polyol pathway flux increase affects ovarian function in polycystic ovary syndrome via excessive oxidative stress.
Wang, Y.-C., Ma, Y.-D., Liu, H., Cui, Z.-H., Zhao, D., Zhang, X.-Q., Zhang, L.-X., Guo, W.-J., Long, Y., Tu, S., et al. (2022) · Life Science · doi:10.1016/j.lfs.2022.121224 · Cited by 16
AMPK Activation as a Protective Mechanism to Restrain Oxidative Stress in the Insulin-Resistant State in Skeletal Muscle of Rat Model of PCOS Subjected to Postnatal Overfeeding
Mićić, B., Djordjevic, A. D., Veličković, N. A., Kovačević, S., Martić, T., Μacut, D., & Milutinović, D. V. (2023) · Biomedicines · doi:10.3390/biomedicines11061586 · Cited by 14
Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development
Katleba, K., Ghosh, P., & Mudryj, M. M. (2023) · Biomedicines · doi:10.3390/biomedicines11082215 · Cited by 14
Serum adiponectin is independently associated with the metabolic syndrome in Hong Kong, Chinese women with polycystic ovary syndrome
Ko, J. K. Y., Li, R., Lam, K. S. L., Tam, S., Lee, V. C. Y., Yeung, T. W. Y., Ho, P. C., & Ng, E. H. Y. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1126708 · Cited by 14
Comparison of Finasteride, Metformin, and Finasteride Plus Metformin in PCOS
Diri, H. (2017) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2017.84 · Cited by 14
Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
Long, T., Zhang, Y., Zeng, C., Zheng, S., Zhou, L., & Liu, H. (2022) · International Journal of Endocrinology · doi:10.1155/2022/9927240 · Cited by 14
Lipid profile abnormalities associated with endocrine disorders
Szczepanek‐Parulska, E., Sokołowski, J., Dmowska, D., Klimek, J., Stasikowski, T., Zdebski, P., Olejarz, M., Gac, A., Bartecki, M., & Ruchała, M. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0059 · Cited by 14
Metabolically Healthy Obesity: Epidemiology, Criteria, and Implications in Chronic Kidney Disease
Cho, Y. K., & Jung, C. H. (2022) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes22036 · Cited by 15
The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol
Khalifah, R. A. A., Flórez, I. D., Dennis, B. B., Neupane, B., Thabane, L., & Bassilious, E. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0105-4 · Cited by 14
Insulin resistance, androgens, and lipids are gradually improved in an age-dependent manner in lean women with polycystic ovary syndrome: insights from a large Caucasian cohort
Livadas, S., Μacut, D., Bothou, C., Kuliczkowska-Płaksej, J., Vryonidou, A., Bjekić-Macut, J., Mouslech, Z., Milewicz, A., & Panidis, D. (2020) · HORMONES · doi:10.1007/s42000-020-00211-z · Cited by 14
Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome
Riemann, A., Blaschke, M., Jauho-Ghadimi, A., Siggelkow, H., & Gollisch, K. S. C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154294 · Cited by 13
AMPK Activation Is Important for the Preservation of Insulin Sensitivity in Visceral, but Not in Subcutaneous Adipose Tissue of Postnatally Overfed Rat Model of Polycystic Ovary Syndrome
Mićić, B., Teofilović, A., Djordjevic, A. D., Veličković, N. A., Μacut, D., & Milutinović, D. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168942 · Cited by 13
Association between self-reported sedentary behavior and health-related quality of life among infertile women with polycystic ovary syndrome
Cao, Y., Li, G., & Ren, Y. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02222-5 · Cited by 17

Authors: Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., Pfeifer, M., Pignatelli, D., Pugeat, M., & Yildiz, B. O.
Affiliations: University College Hospital (GB)
National and Kapodistrian University of Athens (GR)
Universidad Complutense de Madrid (ES)
ORCID: Conway, Gerard
Dewailly, Didier
Escobar-Morreale, Héctor F
Gambineri, Alessandra
Pignatelli, Duarte
Venue: European Journal of Endocrinology
Publisher: Oxford University Press (OUP)
Published: 2014-10
Volume: 171
Issue: 4
Pages: P1-P29
ISSN: 0804-4643 (ISSN-L)
1479-683X
DOI: 10.1530/eje-14-0253
OpenAlex: W1963543729
Semantic Scholar: 518b85a010c577bc0434b3172e959aaf7980d719
Cited by: 676
References: 288
Citations by year: 2026: 24 · 2025: 26 · 2024: 45 · 2023: 73 · 2022: 77 · 2021: 68 · 2020: 58 · 2019: 69 · 2018: 84 · 2017: 53 · 2016: 48 · 2015: 43 · 2014: 6
FWCI: 60.60
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
Locations: European Journal of Endocrinology (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords: polycystic ovary syndrome, PCOS diagnostic criteria, PCOS phenotypes, hyperandrogenism, insulin resistance, obesity, type 2 diabetes, impaired glucose tolerance, early life events, PCOS pathogenesis, biomarkers, sleep disorders, neuropsychological aspects, cardiovascular risk factors, treatment targeting
MeSH terms: Androgens, Body Composition, Cardiovascular Diseases, Concept Formation, Female, Glucose, Humans, Hypoglycemic Agents, Infertility, Female, Insulin Resistance, Obesity, Ovary, Phenotype, Polycystic Ovary Syndrome, Quality of Life, Gonadal Steroid Hormones, Testosterone, Ultrasonography, Lipid Peroxidation, Biomarkers, Glucose Intolerance, Risk Reduction Behavior, Bariatric Surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks